Hidradenitis Suppurativa Diagnosis Not Found to Be Associated With Greater Stroke Risk
A diagnosis of hidradenitis suppurativa was not found to be associated with a greater risk for stroke.
A diagnosis of hidradenitis suppurativa was not found to be associated with a greater risk for stroke.
ST-segment elevation was observed in a cohort of patients presenting to New York City hospitals with COVID-19.
PF-06700841 and PF-06651600 were found to have an effect onset of 6 and 4 weeks, respectively in patients with moderate to severe alopecia areata.